The authors reviewed nine clinical preventive services for maternal cardiovascular health and found sufficient evidence to call for updated clinical guidelines in two areas — better management of chronic hypertension and stronger postpartum blood pressure monitoring.

The conference provides a forum to highlight advances in the care of children and adults with congenital heart disease.

New study suggests that treating patients for CHIP (clonal growth of precancerous blood cells) could reduce their risk of potentially life-threatening heart inflammation.

Hospitals that earn accreditation have proven exceptional competency in treating patients with heart attack symptoms. The new designation will last until Jan. 31, 2029.

The collaboration will leverage VUMC’s resource platform, including its comprehensive datasets hosted in Vanderbilt’s BioVU collection of DNA and plasma to enable data-driven insights and to accelerate discovery and development.

The program recognizes “the critical role of facilities providing care to patients with congenital heart disease who transition their care from pediatric cardiology to adult cardiology services.”

The event, which featured more than 50 teams from VUMC, raises awareness and funds for research, advocacy and CPR training to combat heart disease and stroke.